Jessica Henderson
Psychiatric/Mental Health · Hagerstown, MDNPI 1083227060
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.8% of the total across 317 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 21.1% — the pattern of someone who eats at a lot of different presentations. Among psychiatric/mental health clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 317 payments — averaging $16.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Alkermes, Inc.$569
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$371
- Sunovion Pharmaceuticals Inc.$342
- Otsuka America Pharmaceutical, Inc.$332
- Tris Pharma Inc$266
- plus $2K from 21 others
What the payments were for
- Food & beverage$5,26898%
- Education$1172%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 90 | $1,136 |
| Alkermes, Inc. | 32 | $569 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 18 | $371 |
| Sunovion Pharmaceuticals Inc. | 26 | $342 |
| Otsuka America Pharmaceutical, Inc. | 19 | $332 |
| Tris Pharma Inc | 15 | $266 |
| Lundbeck LLC | 14 | $253 |
| Corium, LLC | 14 | $251 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $247 |
| Neurocrine Biosciences, Inc. | 12 | $233 |
| Supernus Pharmaceuticals, Inc. | 10 | $191 |
| Teva Pharmaceuticals USA, Inc. | 9 | $188 |
| Axsome Therapeutics, Inc. | 7 | $179 |
| Incyte Corporation | 2 | $166 |
| Eisai Inc. | 11 | $157 |
| E.r. Squibb & Sons, L.L.C. | 6 | $122 |
| Vanda Pharmaceuticals Inc. | 4 | $82 |
| Ironshore Pharmaceuticals Inc. | 3 | $64 |
| Vertical Pharmaceuticals, LLC | 2 | $56 |
| Tempus AI, Inc | 2 | $43 |
| Dermavant Sciences, Inc. | 2 | $33 |
| Idorsia Pharmaceuticals US Inc | 1 | $24 |
| Verrica Pharmaceuticals Inc. | 1 | $19 |
| Collegium Pharmaceutical, Inc. | 1 | $18 |
| Avion Pharmaceuticals | 1 | $18 |
| Merck | 1 | $14 |
| Organon | 1 | $11 |
How this compares
$5,385 in reported general payments places this provider in the 95th percentile of 1,461 psychiatric/mental health providers in Maryland.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aripiprazole | 20 | $7,586 |
| Quetiapine Fumarate | 47 | $1,263 |
| Divalproex Sodium ErDivalproex Sodium | 17 | $952 |
| Propranolol Hcl | 12 | $796 |
| Clonazepam | 78 | $764 |
| Divalproex Sodium | 18 | $645 |
| AmantadineAmantadine Hcl | 11 | $566 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 27 | $484 |
| Olanzapine | 18 | $428 |
| Temazepam | 14 | $378 |
| Buspirone Hcl | 19 | $370 |
| Sertraline Hcl | 56 | $314 |
| Prazosin Hcl | 17 | $286 |
| Escitalopram Oxalate | 27 | $251 |
| Trazodone Hcl | 34 | $249 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Hagerstown
- Cb BenwayHagerstown$10K
- Hara OyedejiOwings Mills$780K
- Ilya RozenbergGlen Burnie$572K
- Michelle WilliamsColumbia$158K
- Kristin ClemensGaithersburg$36K
- Antonio HeroldHavre de Grace$23K
- Paul KlaverweidenFruitland$17K
- Margaret WebbAberdeen$16K
- Susan KrausTowson$16K
- Anyinke AtabongRockville$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.